Literature DB >> 23518597

Gluten-sensitive enteropathy coincides with decreased capability of intestinal T cells to secrete IL-17 and IL-22 in a macaque model for celiac disease.

Huanbin Xu1, Stephanie L Feely2, Xiaolei Wang1, David X Liu1, Juan T Borda1, Jason Dufour3, Weiwei Li4, Pyone P Aye5, Gaby G Doxiadis6, Chaitan Khosla4, Ronald S Veazey1, Karol Sestak7.   

Abstract

Celiac disease (CD) is an autoimmune disorder caused by intolerance to dietary gluten. The interleukin (IL)-17 and IL-22 function as innate regulators of mucosal integrity. Impaired but not well-understood kinetics of the IL-17/22 secretion was described in celiac patients. Here, the IL-17 and IL-22-producing intestinal cells were studied upon their in vitro stimulation with mitogens in class II major histocompatibility complex-defined, gluten-sensitive rhesus macaques. Pediatric biopsies were collected from distal duodenum during the stages of disease remission and relapse. Regardless of dietary gluten content, IL-17 and IL-22-producing cells consisted of CD4+ and CD8+ T lymphocytes as well as of lineage-negative (Lin-) cells. Upon introduction of dietary gluten, capability of intestinal T cells to secrete IL-17/22 started to decline (p<0.05), which was paralleled with gradual disruption of epithelial integrity. These data indicate that IL-17/22-producing cells play an important role in maintenance of intestinal mucosa in gluten-sensitive primates.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23518597      PMCID: PMC3732447          DOI: 10.1016/j.clim.2013.02.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  46 in total

1.  STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing.

Authors:  Geethanjali Pickert; Clemens Neufert; Moritz Leppkes; Yan Zheng; Nadine Wittkopf; Moritz Warntjen; Hans-Anton Lehr; Sebastian Hirth; Benno Weigmann; Stefan Wirtz; Wenjun Ouyang; Markus F Neurath; Christoph Becker
Journal:  J Exp Med       Date:  2009-06-29       Impact factor: 14.307

Review 2.  Celiac disease: from pathogenesis to novel therapies.

Authors:  Detlef Schuppan; Yvonne Junker; Donatella Barisani
Journal:  Gastroenterology       Date:  2009-09-18       Impact factor: 22.682

3.  Noninflammatory gluten peptide analogs as biomarkers for celiac sprue.

Authors:  Michael T Bethune; Mónica Crespo-Bosque; Elin Bergseng; Kaushiki Mazumdar; Lara Doyle; Karol Sestak; Ludvig M Sollid; Chaitan Khosla
Journal:  Chem Biol       Date:  2009-08-28

4.  Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

Authors:  Stefanie Eyerich; Kilian Eyerich; Davide Pennino; Teresa Carbone; Francesca Nasorri; Sabatino Pallotta; Francesca Cianfarani; Teresa Odorisio; Claudia Traidl-Hoffmann; Heidrun Behrendt; Stephen R Durham; Carsten B Schmidt-Weber; Andrea Cavani
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

5.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Sean Stevens; Richard A Flavell
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

6.  IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.

Authors:  Kristine E Nograles; Lisa C Zaba; Avner Shemer; Judilyn Fuentes-Duculan; Irma Cardinale; Toyoko Kikuchi; Michal Ramon; Reuven Bergman; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2009-05-12       Impact factor: 10.793

7.  A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity.

Authors:  Marina Cella; Anja Fuchs; William Vermi; Fabio Facchetti; Karel Otero; Jochen K M Lennerz; Jason M Doherty; Jason C Mills; Marco Colonna
Journal:  Nature       Date:  2008-11-02       Impact factor: 49.962

8.  Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.

Authors:  Yan Zheng; Patricia A Valdez; Dimitry M Danilenko; Yan Hu; Susan M Sa; Qian Gong; Alexander R Abbas; Zora Modrusan; Nico Ghilardi; Frederic J de Sauvage; Wenjun Ouyang
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

9.  The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity.

Authors:  Luisa Klotz; Sven Burgdorf; Indra Dani; Kaoru Saijo; Juliane Flossdorf; Stephanie Hucke; Judith Alferink; Nina Nowak; Natalija Novak; Marc Beyer; Gunter Mayer; Birgit Langhans; Thomas Klockgether; Ari Waisman; Gerard Eberl; Joachim Schultze; Michael Famulok; Waldemar Kolanus; Christopher Glass; Christian Kurts; Percy A Knolle
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

10.  A non-human primate model for gluten sensitivity.

Authors:  Michael T Bethune; Juan T Borda; Erin Ribka; Michael-Xun Liu; Kathrine Phillippi-Falkenstein; Ronald J Jandacek; Gaby G M Doxiadis; Gary M Gray; Chaitan Khosla; Karol Sestak
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

View more
  10 in total

1.  Molecular characteristics of rhesus macaque interleukin-22: cloning, in vitro expression and biological activities.

Authors:  Lei Yu; Feng-Jie Wang; Yan-Fang Cui; Dong Li; Wen-Rong Yao; Gui-Bo Yang
Journal:  Immunology       Date:  2018-03-09       Impact factor: 7.397

Review 2.  Interleukin-22: immunobiology and pathology.

Authors:  Jarrod A Dudakov; Alan M Hanash; Marcel R M van den Brink
Journal:  Annu Rev Immunol       Date:  2015-02-11       Impact factor: 28.527

3.  The effects of reduced gluten barley diet on humoral and cell-mediated systemic immune responses of gluten-sensitive rhesus macaques.

Authors:  Karol Sestak; Hazel Thwin; Jason Dufour; Pyone P Aye; David X Liu; Charles P Moehs
Journal:  Nutrients       Date:  2015-03-06       Impact factor: 5.717

4.  Celiac and Non-Celiac Forms of Gluten Sensitivity: Shifting Paradigms of an Old Disease.

Authors:  Karol Sestak; Ilana Fortgang
Journal:  Br Microbiol Res J       Date:  2013-10

5.  Dietary Gluten-Induced Gut Dysbiosis Is Accompanied by Selective Upregulation of microRNAs with Intestinal Tight Junction and Bacteria-Binding Motifs in Rhesus Macaque Model of Celiac Disease.

Authors:  Mahesh Mohan; Cheryl-Emiliane T Chow; Caitlin N Ryan; Luisa S Chan; Jason Dufour; Pyone P Aye; James Blanchard; Charles P Moehs; Karol Sestak
Journal:  Nutrients       Date:  2016-10-28       Impact factor: 5.717

Review 6.  Orchestration of intestinal homeostasis and tolerance by group 3 innate lymphoid cells.

Authors:  Hugo A Penny; Suzanne H Hodge; Matthew R Hepworth
Journal:  Semin Immunopathol       Date:  2018-05-08       Impact factor: 9.623

7.  Beneficial Effects of Human Anti-Interleukin-15 Antibody in Gluten-Sensitive Rhesus Macaques with Celiac Disease.

Authors:  Karol Sestak; Jason P Dufour; David X Liu; Namita Rout; Xavier Alvarez; James Blanchard; Anne Faldas; David J Laine; Adam W Clarke; Anthony G Doyle
Journal:  Front Immunol       Date:  2018-07-11       Impact factor: 7.561

8.  Reduced infant rhesus macaque growth rates due to environmental enteric dysfunction and association with histopathology in the large intestine.

Authors:  Sara M Hendrickson; Archana Thomas; Kamm Prongay; Andrew J Haertel; Laura M Garzel; Leanne Gill; Tasha Barr; Nicholas S Rhoades; Rachel Reader; Mark Galan; Julie M Carroll; Charles T Roberts; Lina Gao; Ian J Amanna; Ilhem Messaoudi; Mark K Slifka
Journal:  Nat Commun       Date:  2022-01-11       Impact factor: 14.919

9.  Supplementation of Reduced Gluten Barley Diet with Oral Prolyl Endopeptidase Effectively Abrogates Enteropathy-Associated Changes in Gluten-Sensitive Macaques.

Authors:  Karol Sestak; Hazel Thwin; Jason Dufour; David X Liu; Xavier Alvarez; David Laine; Adam Clarke; Anthony Doyle; Pyone P Aye; James Blanchard; Charles P Moehs
Journal:  Nutrients       Date:  2016-06-28       Impact factor: 5.717

10.  The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study.

Authors:  Mahmut Yuksel; Mustafa Kaplan; Ihsan Ates; Zeki Mesut Yaln Kilic; Hasan Kilic; Nuretdin Suna; Hale Ates; Ertugrul Kayacetin
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.